Lipid-lowering effect of the new drugs eniclobrate and beclobrate in patients with hyperlipidemia type II a and type II b.
Najemnik C, Lageder H, Regal H, Irsigler K.
Arzneimittelforschung. 1981;31(12):2168-9.
PMID:7037012
Modulation of Hepatic Functions by Chicory (Cichorium intybus L.) Extract: Preclinical Study in Rats.
Krepkova LV, Babenko AN, Lemyaseva SV, Saybel OL, Sherwin CM, Enioutina EY.
Pharmaceuticals (Basel). 2023 Oct 16;16(10):1471. doi: 10.3390/ph16101471.
PMID:37895942
N-3 fatty acids from fish oil. Effects on plasma lipoproteins and hypertriglyceridemic patients.
Connor WE, DeFrancesco CA, Connor SL.
Ann N Y Acad Sci. 1993 Jun 14;683:16-34. doi: 10.1111/j.1749-6632.1993.tb35689.x.
PMID:8352438
[Modification of serum lipids, lipoproteins and apoproteins AI and B in patients with hyperlipidemia Type IIa and IIb using polyenylphosphatidylcholine].
Noseda G, Suvà F, Fragiacomo C.
Schweiz Med Wochenschr. 1985 Jul 27;115(30):1064-70.
PMID:4035328
Tumor necrosis factor‑α and interleukin‑6 suppress microRNA‑1275 transcription in human adipocytes through nuclear factor‑κB.
Zhou YF, Fu ZY, Chen XH, Cui Y, Ji CB, Guo XR.
Mol Med Rep. 2017 Nov;16(5):5965-5971. doi: 10.3892/mmr.2017.7392. Epub 2017 Aug 29.
PMID:28901460
Farnesoid X Receptor and Liver X Receptor Ligands Initiate Formation of Coated Platelets.
Unsworth AJ, Bye AP, Tannetta DS, Desborough MJR, Kriek N, Sage T, Allan HE, Crescente M, Yaqoob P, Warner TD, Jones CI, Gibbins JM.
Effects of cardiovascular risk factors and pre-existing diseases on the short-term outcome of Takotsubo syndrome.
Mousavi RA, Schober A, Kronberger C, Han E, Litschauer B, Pichler G, Badr Eslam R.
Wien Klin Wochenschr. 2024 Dec;136(23-24):691-699. doi: 10.1007/s00508-024-02326-4. Epub 2024 Feb 6.
PMID:38319434
Laparoscopic bariatric surgery: what else are we uncovering? Liver pathology and preoperative indicators of advanced liver disease in morbidly obese patients.
Kroh M, Liu R, Chand B.
Surg Endosc. 2007 Nov;21(11):1957-60. doi: 10.1007/s00464-007-9351-4. Epub 2007 May 4.